HELEN MCGLASHEN: Open Payments
NPI 1568160653 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,698 in 50 payments from 14 companies in 2025. Trend: 2023 $365 · 2024 $1,122 · 2025 $1,698
Food & beverage: $1,633Education: $65
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $519 |
| UCB, Inc. | 13 | $350 |
| Janssen Biotech, Inc. | 4 | $233 |
| Arcutis Biotherapeutics, Inc. | 4 | $173 |
| ABBVIE INC. | 5 | $104 |
| GENZYME CORPORATION | 2 | $84 |
| Organon LLC | 7 | $63 |
| Incyte Corporation | 2 | $41 |
| Almirall LLC | 2 | $34 |
| LNHC, Inc | 1 | $22 |
Products named: DUPIXENT, Bimzelx, TREMFYA, Zoryve, SKYRIZI, VTAMA, OPZELURA, Klisyri.
Industry payments across AZ — which companies pay providers there.
